Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Rie Mineta"'
Autor:
Satoshi Saitoh, Masahiro Kobayashi, Yukiko Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Norio Akuta, Tetsuya Hosaka, Rie Mineta, Shunichiro Fujiyama, Hitomi Sezaki, Kenji Ikeda, Fumitaka Suzuki, Yusuke Kawamura, Mariko Kobayashi, Hiromitsu Kumada
Publikováno v:
Hepatology Research. 51:503-508
Tenofovir disoproxil fumarate (TDF) is widely used to treat hepatitis B virus (HBV) patients worldwide. We previously reported a patient with CHB and cirrhosis in whom viral breakthrough occurred during combination therapy with TDF and entecavir (ETV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::755216089fc076718baee32fa9cde884
https://doi.org/10.1111/hepr.13618
https://doi.org/10.1111/hepr.13618
Autor:
Yoshiyuki Suzuki, Masahiro Kobayashi, Norio Akuta, Fumitaka Suzuki, Shunichiro Fujiyama, Tetsuya Hosaka, Yusuke Kawamura, Hitomi Sezaki, Yukiko Suzuki, Hiromitsu Kumada, Mariko Kobayashi, Kenji Ikeda, Yasuji Arase, Rie Mineta, Satoshi Saitoh
Publikováno v:
Journal of Gastroenterology. 52:641-651
Few studies have investigated the efficacy of long-term tenofovir disoproxil fumarate (TDF)-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs. We retrospectively analyzed 40 Japanese patients with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680739c5b41915cf7a975116369f76c0
https://doi.org/10.1007/s00535-016-1270-5
https://doi.org/10.1007/s00535-016-1270-5
Autor:
Hitomi Sezaki, Fumitaka Suzuki, Rie Mineta, Satoshi Saitoh, Norio Akuta, Kenji Ikeda, Yusuke Kawamura, Yoshiyuki Suzuki, Tetsuya Hosaka, Yukiko Suzuki, Yasuji Arase, Hiromitsu Kumada, Mariko Kobayashi, Shunichiro Fujiyama, Masahiro Kobayashi
Publikováno v:
Journal of gastroenterology. 54(2)
We determined the antiviral potency and viral breakthrough rate after 10 years of continuous entecavir treatment in patients with chronic hepatitis B (CHB) infection. The cumulative rates of undetectable hepatitis B virus DNA (HBV-DNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7b7ddc2d1c0409c21fd8fb18980244
https://pubmed.ncbi.nlm.nih.gov/30136216
https://pubmed.ncbi.nlm.nih.gov/30136216
Autor:
Hiromitsu Kumada, Masahiro Kobayashi, Yasuji Arase, Mariko Kobayashi, Satoshi Saito, Keiji Aoki, Tetsuya Hosaka, Yoshiyuki Suzuki, Yoshiyuki Nakayasu, Sachiyo Watahiki, Kenji Ikeda, Norio Akuta, Fumitaka Suzuki, Hidetaka Tsuda, Rie Mineta, Yuya Seko, Ichimaro Yamada, Hitomi Sezaki, Yusuke Kawamura
Publikováno v:
Hepatology Research. 43:691-701
Aim The aims of this study are to assess the antiviral effects, safety and telaprevir (TVR) pharmacokinetics in two cohorts given TVR every 8 h (q8h) at doses of 500 mg and 750 mg with peginterferon-α-2b and ribavirin in chronic hepatitis C patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::301b398d24ec5f1d323efdbd19e96576
https://doi.org/10.1111/hepr.12009
https://doi.org/10.1111/hepr.12009
Autor:
Hitomi Sezaki, Satomi Iwasaki, Tetsuya Hosaka, Yoshiyuki Suzuki, Norio Akuta, Hiromitsu Kumada, Hiromi Yatsuji, Fumitaka Suzuki, Yasuji Arase, Mariko Kobayashi, Yuzo Miyakawa, Rie Mineta, Kenji Ikeda, Masahiro Kobayashi, Sachiyo Watahiki
Publikováno v:
Journal of Medical Virology. 80:1880-1884
During 35 years from 1971 to 2005, 153 patients with acute and 4,277 with chronic HBV infection visited the Toranomon Hospital in Tokyo, Japan. They were grouped into seven 5-year periods, and HBV genotypes/subgenotypes were determined. Patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69ab279d795e9f94d7c1374b01f8b4a
https://doi.org/10.1002/jmv.21309
https://doi.org/10.1002/jmv.21309
Autor:
Yoshiyuki Suzuki, Yusuke Kawamura, Hiromi Yatsuji, Miharu Hirakawa, Yasuji Arase, Satomi Iwasaki, Mariko Kobayashi, Rie Mineta, Fumitaka Suzuki, Tetsuya Hosaka, Hitomi Sezaki, Satoshi Saitoh, Hiromitsu Kumada, Masahiro Kobayashi, Kenji Ikeda, Sachiyo Watahiki, Norio Akuta
Publikováno v:
Kanzo. 51:196-198
A 51-year-old Japanese woman with chronic hepatitis B who had never treated with nucleotide analogues was admitted to our hospital and treated with entecavir. In this patient, entecavir successfully reduced the HBV level, but viral and biochemical br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b4d0fd3ba7c3f2d55adb47400c33714
https://doi.org/10.2957/kanzo.51.196
https://doi.org/10.2957/kanzo.51.196
Autor:
Yoshiyuki Suzuki, Miharu Hirakawa, Kenji Ikeda, Satoshi Saito, Masahiro Kobayashi, Tetsuya Hosaka, Fumitaka Suzuki, Hiromitsu Kumada, Mariko Kobayashi, Yasuji Arase, Rie Mineta, Norio Akuta, Satomi Iwasaki, Hitomi Sezaki, Yusuke Kawamura, Hiromi Yatsuji, Sachiyo Watahiki
Publikováno v:
Journal of Clinical Virology. 47:76-78
Here, we describe for the first time a case of sustained virological response (SVR) achieved in a patient with chronic hepatitis C (CH-C) by monotherapy with a NS3-4A protease inhibitor, telaprevir, without interferon therapy. A 59-year-old treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e64582c66404e1809dc4f408d8dc9711
https://doi.org/10.1016/j.jcv.2009.09.029
https://doi.org/10.1016/j.jcv.2009.09.029
Autor:
Kenji Ikeda, Yasuji Arase, Rie Mineta, Satoshi Saitoh, Hiromitsu Kumada, Sachiyo Watahiki, Tetsuya Hosaka, Mariko Kobayashi, Hitomi Sezaki, Masahiro Kobayashi, Norio Akuta, Tasuku Hara, Yusuke Kawamura, Fumitaka Suzuki, Yoshiyuki Suzuki
Publikováno v:
Journal of gastroenterology. 49(6)
Few studies have investigated the emergence of multidrug resistance to adefovir dipivoxil (ADV) plus lamivudine (LAM) combination therapy for patients with LAM-refractory chronic hepatitis B (CHB). In this retrospective study, we investigated the lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ea8019c5ef51acf269bb9d44c197191
https://pubmed.ncbi.nlm.nih.gov/23929069
https://pubmed.ncbi.nlm.nih.gov/23929069
Autor:
Fumitaka, Suzuki, Yoshiyuki, Suzuki, Hitomi, Sezaki, Norio, Akuta, Yuya, Seko, Yusuke, Kawamura, Tetsuya, Hosaka, Masahiro, Kobayashi, Satoshi, Saito, Yasuji, Arase, Kenji, Ikeda, Rie, Mineta, Sachiyo, Watahiki, Mariko, Kobayashi, Yoshiyuki, Nakayasu, Hidetaka, Tsuda, Keiji, Aoki, Ichimaro, Yamada, Hiromitsu, Kumada
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 43(7)
The aims of this study are to assess the antiviral effects, safety and telaprevir (TVR) pharmacokinetics in two cohorts given TVR every 8 h (q8h) at doses of 500 mg and 750 mg with peginterferon-α-2b and ribavirin in chronic hepatitis C patients.Twe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8436bf196e73e15a9e2688186b025e27
https://pubmed.ncbi.nlm.nih.gov/23190247
https://pubmed.ncbi.nlm.nih.gov/23190247
Autor:
Yuya Seko, Sachiyo Watahiki, Hitomi Sezaki, Satoshi Saito, Mariko Kobayashi, Fumitaka Suzuki, Hiromitsu Kumada, Norio Akuta, Rie Mineta, Yusuke Kawamura, Yasuji Arase, Masahiro Kobayashi, Yuzo Miyakawa, Tetsuya Hosaka, Kenji Ikeda, Yoshiyuki Suzuki
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 54(4)
Background Hepatitis C virus (HCV) of genotype 1b is the most prevalent worldwide, and the least responsive to interferon-based treatments. A combination therapy with two direct-acting antivirals has shown promising results in patients with HCV-1b, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::758c106a598d6f17b9e8ed852284392c
https://pubmed.ncbi.nlm.nih.gov/22658798
https://pubmed.ncbi.nlm.nih.gov/22658798